Northwest Biotherapeutics Inc (NASDAQ:NWBO)

CAPS Rating: 1 out of 5

Recs

6
Player Avatar zzlangerhans (99.81) Submitted: 10/20/2011 1:32:30 AM : Outperform Start Price: $8.00 NWBO Score: -82.11

Make no mistake. Northwest Biotherapeutics is a terrible, unscrupulous company that wouldn't hesitate twice to mislead investors and desperate patients alike. I wouldn't invest in Northwest if I knew the share price would double the next day. But this is CAPS, and the company can't use my green thumb for nefarious purposes the way they would use my real investment to dilute at a higher share price.

Northwest's angle these days is a resumption of the phase II trial of DCVax in glioblastoma multiforme that was frozen in 2008 after 33 patients had been enrolled. The company now plans to jack the enrollment up to 240 patients. But an examination of the company's PR shows that they're mostly focused on expanding clinical sites, rather than recruitment of actual patients. You won't find any updates on enrollment, or God forbid a quarterly earnings PR. The company burned 3.5M in operations last quarter, funded by both dilutive and debt financings. With 7M in cash and 12M in debt at the end of last quarter, it's a virtual certainty that Northwest won't be able to carry their phase II trial through to completion the way it is currently structured. When they beat their chest about an FDA clearance for a 612 patient trial of DCVax in prostate cancer, I can only shake my head in disgust.

You might wonder about the venom in my description of this company. A lot of my revulsion stems from the company's decision to include patient testimonials in their PR, along with more pedestrian misrepresentations. I'm also very familiar with the rogues the company appears to have hired to pump their stock. And finally I'm getting sick of the unopposed and flagrant promotion that appears on lame "investing" sites like Seeking Alpha. So the gloves are coming off.

The green thumb is there simply to collect points. Northwest won't die quietly, as management seems committed to squeezing every last nickel out of every bagholder to maintain their salaries as long as possible. I'm trying to hop on an upward move before pulling out a much more appropriate red thumb.

Report this Post 6 Replies
Member Avatar HarryCaraysGhost (99.71) Submitted: 9/27/2012 3:11:05 PM
Recs: 0

Good call ZZ. I now have a new worst performer at negative 660ish based on my red thumb...for now...

Member Avatar TSIF (99.96) Submitted: 9/28/2012 3:53:49 PM
Recs: 1

It won't be negative 1,000+ after the 16:1 gets adjusted.
Use the contact us link,
Other,
and report these reverse splits. These little PK companies don't get the feed automatically.

Still this should have put it sub-$6 so until it levels off zz still gets upward of 100 points..... ;)

Low float may stay erratic...possibly some share holders are trapped until their brokerage catches up.

Member Avatar BravoBevo (99.97) Submitted: 10/1/2012 12:42:41 AM
Recs: 0

nice pick and great patience, zz!
"Don't overstay a good position; you're bound to overstay a bad one."

Member Avatar RRobertsmith (< 20) Submitted: 10/1/2012 5:56:15 PM
Recs: 0

a stop loss order at 40-50% would have prevented this massive score loss....and reinforced good trading practices....10/01/2012

Member Avatar TSIF (99.96) Submitted: 10/2/2012 3:25:35 PM
Recs: 0

There was no massive score gain, nor no massive score loss to be had. A brief check, besides my comment/pitch would show that a 1:16 reverse split had to be processed. A potential 10-20 points did still exist, but a stop loss would not have helped as this one is gapping 10-20% on low volume trades. GAPS are also a reason that stop losses in general may or may not be a good idea in areas of high Beta/volitility.

Member Avatar MyCruiseWright2 (67.44) Submitted: 11/18/2013 7:47:37 PM
Recs: 0

Well zz it seems like the FDA just gave them a big thumbs up today, they are pretty unscrupulous too...did you ever think that maybe this is a small co. that really believes in it's potential just like many other small players...or do you think all big pharma are all good guys.

Featured Broker Partners


Advertisement